NYSA CTR 1
February12,1996 The Council for Tobacco Research - USA, Inc. Supporting Biomedical Investigation
Abstract
The Council for Tobacco Research - USA, Inc. Supporting Biomedical Investigation 900 3rd Avenue New York, NY10022 Tel:
Fields
- Named Organization
- American Association for the Advancement of Science
- CBS (Columbia Broadcasting System)
- Centers for Disease Control and Prevention (CDC)
- Cold Spring Harbor Laboratory
- Columbia University
- Council for Tobacco Research - USA (CTR) (Formerly Tobacco Industry Research Committee (TIRC))Originally organized as the Tobacco Industry Research Committe(TIRC) in 1954, and renamed Council for Tobacco Research - USA, Inc. (CTR) in 1964.
- John Wiley & Sons (Publisher)
- Kaufman (Advertising Agency)
- Memorial Hospital
- National Institutes of Health
- Sega
- Named Person
- Kestler, Harry W.
- Kingston, Brent R.
- Leet, Hye Young
- Lieberman, Howard B.
- Date Loaded
- 11 Jan 2006
- Box
- 0221
Document Images
the
chddren s
memorial
hospital
2300 children's plaza
chicago, illinois 60614
312 ~80-4t~3
February12,1996
The Council for Tobacco Research - USA, Inc.
Supporting Biomedical Investigation
900 3rd Avenue
New York, NY10022
Tel: (212)421-8885
RE: .~ ":-,,6an for Research Support
Dear Sir/Madam:
Enclosed please find a copy
for Tobacco Research for con
Title of the project: Induct
Actio
Phone number: (312)880.
Duration of the project: '
The estimated first year',
If you will have any ques
in the above address.
Thank you.
it to The Council
.echanisms of
eel free to contact me
Sincerely,
Yuqi Zhao, Ph.D.

,children's
memorial
hospital
23C~3 children% plaza
chicago, illinois @3614
312 8813-4000
TeL. (312)C-<30-~605
Fa~: (3121~0-6609
February 12, 1996
The Council for Tobacco Research - USA, Inc.
Supporting Biomedical Investigation
900 3rd Avenue
Nexv York, NY10022
Tel: (212)421-8885
Application for Research Supp,-~rt
Dear Sir~,iadam:
Enclosed please find a copy of the research grant proposal I wish tu submit it to The Council
for Tobacco Research for consideration of a two-year research grm:t.
Title of the project: Induction of Cell Cycle G2 Arrest by HIV-I Vpr: Mechanisms of
Action.
Phone number: (312)880-6608; Fax number: (312)880-6609
Duration of the project: Two years
The estimated first year's annual direct cost: $75,000
If you will have any questions with regard to this application, pleases feel free to contact me
in the above address. I am looking forward to hearing from you soon.
Thank you.
Sincerely,
Yuqi Zhao, P~,.D.

Project Description
Title
Induction of cell cycle G2 arrest by H~r-1 Vpr: dechanisms c~f :~c~i~n
Abstract
Recent studies showed that HIV-1 Vpr induces cell cycle G2 arrcs: by mediating host cell cycle
control process (Rogel et al., 1995; Jowett et al., 995). Studies t'ur~iacr dernonstmted that Vpr
inactivates p34*~'~/cyclin B complex by perturbin. ~ upstream regulators of this complex (Re et al.,
1995; He et al., 1995). In this stud3', we will use he fission yeast &'hic,~saccharomycespombe
as a model system to investigate the specific time :ion of HIV-1 Vpr in association with cell cycle
G2 arrest. Cell cycle G2/M checkpoint control is a highly conserved process among all
eukaryotes. In fact, a number of cell cycle control genes are interchangeable between human and
fission yeast. Our preliminary study showed that HIV-1 Vpr induces 152 ma'est in b: pombe.
Other cellular changes (e.g., morphological chan~ es and growth dela.v~ induced by HIV-1 Vpr in
S. pombe also mimicked those observed in humar cells. Theretbre. S. pombe provides a unique
model system for us to study HIV-1 Vpr function in mediating host cell cycle control process.
Our specific aims are I> to determine which cell ,;ycle control pathxvay Vpr mediates to induce
cell cycle G2 arrest, and 2> to identify the cellula" protein(s) that Vpr directly interacts with in
the G2-inducing process.
Background and Significance
Function of the Vpr Vpr affects various human cellular function~, including prevention of cell
proliferation (Rogel et al., 1995), changes in cell ~norphology (Levy' ctal., 1993; Re et al., 1995)
and induction of cell cycle G2 arrest (Jowett et al., 1995; He et al.. ~,mS. Re et al., 1995).
Mechanistically, Vpr induces G2 arrest by inhibit ng the activities of p34':'t~-~ and cyclin B (Re
et
al., 1995; He et al., 1995), two highly conserved 1: roteins that control cmry of mitosis or G2
arrest in all eukaryotic cells (Norbury and Nurse, t989; Morgan, 1995). These results suggested
that effect ofI-~V-1 Vpr on cell cycle G2
arrest is mediated through a common cellular
process and should be highly conserved
between human and S. pombe (see the Table
below).
Use of fission yeast as a model system to
study the role of Vpr in cell cycle G2 arrest
Fission yeast is a monocellular eukaryote,
which resembles higher eukatTotic cells in
many respects. For example, it divides in a
binary fashion and has a .typical cell cycle. A
S pombe chromosome replicates
autonomo~Iy in mouse cells (Allshire et al.,
I987). Many mammalian genes can be
properly expressed in S pombe cells using
• I
~. pombe Mammalian References
genes homologues
c :lc2 Human CDC2Hs
Mouse CDC2
c:lc13 Human cyclin B
c~lc25 Human CDC25Hul
Human CDC25Hu2
Mouse homolg
weel Human tVEE1Hu
Mouse
s-~c l Htmaar~
rTd9 R~touse
r :d24/25Htmaan 14-3-3
Lee & Nurse, 1987
Spun: et al., 1990
Ozon 1991
Sadhu et al., 1990
Nagata et al., 1991
Okazaki et al., 1990
Igarash~i et al., 1991
Okazaki et aL, 1990
/~Jchardson et aL I990
Zhao et al.~ 1992
Ford et aI. 1994

).ea~.t or human viral prorr oters (including HIV LtR and ye~t ~,~ :' pa,moters), or vi:e ve~s~
ITo,.ama et al., 199,; Mat ndreI1. 19Dl.ll. The conser'¢ation of cell cx tic control pro:ess
l:et'.'.e<~~.
higher e~:aryotes and S ,~ ombe can t:e clearly demons'~rated by functional comptemertation of a
number ofS. pombe cell c ¢cle control mntank,~ by human hamologu~'s (see the above "l'able).
Furthermore, S'. pornbe is a haploid organism, genetically tractable. :rod amendable to many
lnolecular and laboratory manipulations (for reviews see, Zhao and Licb~:rman, 1993, 995). In
fact, a wide array ofS. po~rbe mutants, that are defective in pathwa.vs leading to cell Cl.,cle G2
arrest, are available for th~ proposed study (see the Figure below). Tl~erefore, S. pombc provides
a unique system for us to determine which cell cycle control path~ay Vpr mediates to trigger cell
cycle G2 arrest. In additk.n, the use of a protein-protein interaction detection assay (t~ co-hybrid
system) allo~vs us to ident:fy the specific cellular proteins that inter~,:~ directly with Vpr in G2
induction.
Cell cycle control patln, ~vs that could lead to G2 arrest Mutation_-_ iu any of the fol owing
key
cellular components or regulatory pathways will lead to cell cycle G2 arrest in S. poml e cells:
¢dc2
p34 /¢yehn B complex:. Association of
p34'~¢-~ to cyclin B and its j~hosphorylation
status determines the onse. of mitosis or G2
arrest.
p_34eae2 regulators:
cdc25: a mitotic inducer
wee1 and mikl: mitotic inl,ibitors
pp2A: regulator of cdc25 and wee I
Control
Genes
radl, 3, 9,17
husl, rad26
The G2/M checkpoint con rol pathway: ~
At least nine genes have bt:en identified in this
pathway. The relationships between these genes are unknown. They may function in m orderly
or complex process.
.Cyelin B proteo|ysis:, bus.; gene may be involved in degradation of cyclin B, which is required
for exit from mitosis (AI-I~ hodairy et al., 1995; Seufert et al., 1995 ~
Broad goals and specific aims
The speeitie aims of this ~tudy are 1> to determine which cell cycle control pathway -IIV-1 Vpr
mediates and, 2> to identit~r the specific cellular protein(s) Vpr interacts with in the process of
ceil cycle G2 arrest induction.
A number of recent studies have suggested that Vpr may play an important role in th~ HIV
pathogenesis by preventing cell proliferation (Rogel et al., 1995), activating viral replit:ation
(Marzio etal., 1995) and r.:gulating viral latency (Le'.2¢ et al., 1994~, Hence, the long-term
goaI~
of this project are to under ;land the nature of HIV-I Vpr action in pzrturbing cellular 1: rocess,
and to search for ways to l:lock Vpr-induccd cellular catastrophe and viral replication. By using
the described S pombe syr tern, we will be able to narrow down which cellular G2-con rolling
pathv, ay Vpr mediates and ultimately, to assign its specil~c interact i ~,~ ~s ~.~ ~th ho~ cellular

CD-RP.E~-,rrLY ACTIVE G~TTS, CON-TIL~CYS ~d OTI~R SOLACES of~S
Li~ ~ci~ ~ppo~ (~e~ co~, o~y) from aI~ sources, incladi~ o,,~ institution.
Sources Totfl V~ue Cu~ent
Title of Project
Junior Faculty Award
numbers)
Chicago
Pediatric
Faculty
Foundation
Date of
of Cu-ant
(direct co.-m)
$135,000
Annual Amoum
Available
to You
$~5,000
Termination
of Grant
7/30/97
Identify. and describe any overlap oftMs application with the above grants:
Part of th~s fund ~s used to initiate the proposed pcoject.
Indicate the total annual funds available to you this year for all researci~
!
projects under your supervision. I $ 45,000
PENDING OR PLANNED
Title of Project Sources Total Value Avg..Annual
Total
(give grant of Grant Amount
Duration
numbers) (direct costs) Available to You
(give inclusive
dates)
RadiatEon Mutagenes~s in a
New Gene System
NIH ROI
034,357
$!I0,000
Identi~ and describe any overlap of this application with the above project,
7/1/96-6/30/2(
There is no scientific nor budgetary.-" overlap ~rith tl~c proposed project.
100

proteins inv,~Ived in inductit~n of cell cycle G2 acre.q. -l~e obtainc,i rc.,ults trc, m th~s
pr,~ecl v.ilI
be m~dotabte_-11y invaluable in heIping us to understand the sFecific iclc c f Vpr in patlaogenesis
of
HIV-I infee ion.
Suppnrting data
In a prelin inary study, we successfully cloned and expressed tl~e I-II V-1 Wr gone in ~,2
p~mlb,'
cells as conl~rmed by immunoblot analyses. The ~r gone was clox:¢d into tlxree derivatives of a
yeast expression vector pREP ~.~asi et al., 1993). Each derivatix c ~ .,pro: sos ~7)t" gone at
different
levels. By using an inducible nmtl promoter (Maundrell, 1990). ~vc were also able to induce and
repress HIV-I ~7~r gene expression in the presence (~pr gone-OFF) and absence (~pr gene-ON) of
thiamine in growth media. This feature allows us to test the Vpr-spccifit effects on cellular
functions by switching the ~pr gene ON or OFF. Our results indicmed that Vpr indeed induce
cell cycle G2 arrest in S. pombe cells as determined by flow eytometry analyses and DAPI
nucleus stairdng method. In addition, the effects of Vpr on other cellular changes of S. po,nbe
also mimicked those of observed in human cells. Namely, Vpr altm cd cell morphology and
prevented cell proliferation. Vpr's effects on these cellular changes in X pombe was lbund to
correlate with the levels of vpr gone expression. Our results valida~c~i th: utility ors. ,oombe as
a
useful model system to investigate HIV-1 ~pr gone functions. Resulzs of this preliminary study
have been submitted for publication (Zhao et al., 1995, see the enc!oscd manuscript).
Experimental Design and Procedures
Other studies by coimmunoprecipitation (Re et al., 1995) and imn',ul~oblot analyses (He et al.,
1995) sugge:;ted that Vpr does not interact directly with p34~'~/cycim B :omplex, indicating Vpr
may perturb upstream regulators of this complex. We hypothesizc that Vpr either activates
mitotic inhibitors (i.e., ~veel and mikl) or inhibits a mitotic induce'. (i.e.. cdc25, pp2A). This
could be a direct protein-protein interaction or through one of the several G2-inducing pathways
(Hypothesis A). Alternatively, Vpr could also act as m~ independc~ 4 mitotic ilthibitor. It may
interact with other gene products that are currently unrecognized (ttypothesis B).
To test the first hypothesis, we will express the vpr gene under various cell cycle G2 arrest-
deficient backgrounds (Refer to the figure for a list of these mutants avaitable for this study).
Suppression of Vpr-induced G2 arrest under a specific gone deficient background will allow us
to determine what type of the genetic defects or which cell cycle control pathway Vpr is involved
in inducing (}2 arrest. The cell cycle G2 arrest will be measured by flow cytometry and
confirmed by a conventional DAPI staining method. Phosphorylation status of the p34~°~ will be
determined using an immunoblot analysis method described by Hayles m~d Nurse, (1995).
To test the second hypothesis, we will use a yeast two-hybrid system (originally described by
Fields and Song, 1989. Test kits are now commercially available f~r ,S' l~ombe from several Bio-
teeh companies). This assay is specifically designed for genetic screening of protein-protein
interactions. It has been used widely for various eukaryotic systems and proven useful for
identifying h~teractions between a known protein and previously unidentified proteins. To
prepare for this assay, we have subeloned the HIV-1 vpr gone int~ a bait plasrnid pGBTg, which
~,dll be used in this system as a target for potential cellular protein bindings.
505~08

Biographical Sketch
(Yuqi Zhao)
Assistant professor, Department of Pediatrics, Net'&western University Medical School
Director, Molecular Diagnostics Lab., I-IW Program for Children and Mothers, The
Children's Memorial Hospital, Chicago, 1994-present
Research .Associate Scientist, Department of Radiation Oncology, College of Physicians
& Surgeons, Columbia University, 1992-1994
Education and professional training:
Postdoc., College of Physicians & Surgeons, Columbia Univ. (Moi. biology), 1991-92
Ph.D., Oregon St. University (Microbial genetics and molecular biology), 1991
M.S., Oregon St. University (Genetics), 1985
B.S., Shandong College, China (Biology), 1981
Pertinent Editorial and Professional Services:
Member of HIV Drug Resistance Sequencing Team, AIDS Clinical Trial Groups
(ACTG), 94-present
Member of HIV in situ Drug Resistance Screening Team, ACTG. 1995-present
Consultant for biological sciences, Science Press, New York Ltd., 1996-
Member of editorial board, Clinical Immunology Newsletter, 1995-present
Member of editorial board, Journal of Bio-seienee and Technology, 1993-1994
Member of editorial board, Current Ag. Science and Technology. 1990-1994
Membership of professional societies:
The AIDS Clinical Trail Group (ACTG)
American Society for Microbiology
American Association for the Advancement of Science
American Pediatric Infectious Diseases Society
American Radiation Research Society
Relevant and/or Recent Scientific Publications:
Zhao, Y., J. Cao, J. Tian, M.ILG. O'Gorman and R. Yogev. 1996. HIV-I ~pr gene
induces changes of cell morphology and cell cycle 132 arrest in fission yeast
Schizosaccharomycespombe. Presentation at 3rd Conference on Retorviruses and
Opportunistic Infections, Washington. D.C. $8-21.
Zhao, Y,, J. Cao, J. Tian, M.1LG. O'Gorman and R. Yogev. 1996. Expression of HIV-1
~77r gene induces changes in fission yeast Schizosaccharom3'ces pombe similar to
those induced in human ceils (Abst). Keystone Syrup. on Molecular Biology of
Hrv. Taos, NM. B1.-455.

Zhao, Y., J. Cao, NI.R.G. O'Gorrns.n -and R. Yogev. 1995. Effect c, fhurnan
immunedeficieney viru~ t)l~e 1 protein R (~:pr) gene exprezsion on basic celluI~
function of fission yeast Schizosaccharomyces pombe tSubmitted).
Zhao, Y., W. Kabat, T. Yeghiazarian, J. W'flber and R. Yogev. 1 qq5. Presence ofnon-
,Arion associated p24 antigen of human immunodeficiencv virus type 1 (HI¥-1) in
plasma of HIV-irtfeeted eb, ildren (Submitted).
Zhao, Y. and H.B. Liebermann. 1995. Schizosaccharomycespombe: a model
system for molecular studies ofeukaryotie genes. DNA and Cell Biology
14(5):359-371.
Li, Y. and Y. Zhlo (eds.) 1995, 1996. Practical Protocols in Molecular Biology.
Science Press, New York Ltd. and Academia Sinic~ Beij ing.
Kabat, W., T. Yeghiazafian, J. Wilber, Y. Zhao, and 1L Yogev. 1995. The use era
modified branehed DNA signal amplification method to measure human
immunodefieieney vires type 1 plasma viral RNA in pediatric population (Abst).
Nineteenth AIDS Clinical Trails Group Meeting, XVashington, DC., Abstract #8.
Yeghiazarian T, W. Kabat, J. Wilber, Y. Zhao, R. Yogev. 1995. Quantitation of human
immunodefieieney virus type 1 (HIV-1) RNA level in pediatric population using a
modified branched DNA signal amplification method (Abst). [CAAC, San
Francisco, CA, 1-161, p.233.
DeMeter L, A Erice, D Mayers, ... Y. Zhao, et al., 1995. Interlaboratory concordance of
DNA sequence analysis of the HIV-1 reverse transcdptase (Abst). ICAAC, San
Francisco, CA, 1-284, p.256.
Zhao, Y. and S. Liu. 1995. The use of oneogenes and tumor suppressor genes
as the biomarkers for the early detection of the human colon cancer. Clinical
Immunology Newsletter 15(5):65-69.
Zhao, Y. and W. Kabat. 1994. New viral markers and their detection methods for
clinical studies of human immtmodeficieney virus type !. Clinical Immunology
Newsletter. 14(7): 111-117.
Zhao, Y., L. Godparthi, and H.B. Liebermann. 1994. A new shuttle vector system
for the identification of spontaneous and radiation-induced mutations in the
fission yeast Schizosaccharomycespombe. Mutation Res. 311:111-123.
Zhlo, Y. and H.B. Liebermann. 1993. The isolation and analysis of mammalian genes
using yeast as a host for cloning and expression. J. ofBio. Sci. & Teeh.
1:20-27.
Zhao, Y., K.M. Hopkins, and H.B. Liebermann 1993. A method lbr long-term
storage and high efficiency transformation of competent fission yeast cells.
BioTeehniques. 15(2):238.
Zhao, Y., K.M. Hopkins, and H.B. Lieberman. 1992. Identification and isolation of the
mammalian cognate of the Schizosaccharomycespombz tad9 gene. CRR Report,
Columbia Universit?,.,. 111-114.
Romantschuk, M., Y. Zhan, K. McCluskey, J. Williams, and D. Mills. 1990
Repetitive sequences in Pseudomonas syringae pv. phaseolicota: distribution and
possible function as insertion sequences. Symbiosis.
595=~10

Effect of Human Immunodeficiency Virus Type 1 Protein R (~p/l Gene Expression on
Basic Cellular Function of Fission Yeast Schizosaccharomyces pombe
Running title: HIV-1 vpr gene expression in fission yeast
Yuqi Zhao*~, Jian Cao, Maurice R.G. O'Gorman, and Ram Yogev HIV Program for Children
and Mothers, The Children's Memorial Hospital, Chicago, and Department of Pediatrics,
Northwestern U~versity Medical School
~Corresponderxt Footnote: * Corresponding author. Mailing address: 24-30 N. Halsted
Street, #218, Chicago, IL 606I~-. Phone: (312)880-6608. Fax: (312)~0-6609. Electrode mail
address: yzhao~wu.edu

2
Abstract
The HIV-1 vpr gene has been reported effect basic human cellular function, including
prevention of cell proliferation, changes in cell morphology and ~nducz[on of cell eyele G2 arrest.
:
In this study, we used the fission yeast Schizosaccharomycespombe as a model system to
investigate the cellular effects of HIV-1 vpr gene expression. The ~r gene was cloned into three
derivatives of an inducible gene expression vector pREP. Each derivative allows different level
of basal gene expression that can be repressed or induced in the pre~ence or absence Of thiamine.
Induction of HI-V-1 vpr gene affects S. pombe at colony, cellular and molecular levels.
Specifically, Vpr induces reduced colony size, high diversified ce!l morphology, ~owth delay
and cell cycle G2 arrest. These phenotypie changes correlated with the levels of vpr gene
expression. Our results suggest that HIV- I Vpr-indueed cellular changes i~ S. pombe rrtmAe
those observed in human cells. Therefore, S. pombe system is suitco tbr investigation of the
HIV-1 vpr gene function.
505~4412
